These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11060708)

  • 1. Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.
    Yamada KA
    Expert Opin Investig Drugs; 2000 Apr; 9(4):765-78. PubMed ID: 11060708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
    Yamada KA
    Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer.
    Bernard K; Danober L; Thomas JY; Lebrun C; Muñoz C; Cordi A; Desos P; Lestage P; Morain P
    CNS Neurosci Ther; 2010 Oct; 16(5):e193-212. PubMed ID: 21050420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA receptor modulators as cognitive enhancers.
    Lynch G
    Curr Opin Pharmacol; 2004 Feb; 4(1):4-11. PubMed ID: 15018832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPA receptor potentiators as cognitive enhancers.
    O'Neill MJ; Dix S
    IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA Receptors as Therapeutic Targets for Neurological Disorders.
    Lee K; Goodman L; Fourie C; Schenk S; Leitch B; Montgomery JM
    Adv Protein Chem Struct Biol; 2016; 103():203-61. PubMed ID: 26920691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory and the brain: unexpected chemistries and a new pharmacology.
    Lynch G
    Neurobiol Learn Mem; 1998; 70(1-2):82-100. PubMed ID: 9753589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of AMPA receptor kinetics differentially influences synaptic plasticity in the hippocampus.
    Arai AC; Xia YF; Suzuki E
    Neuroscience; 2004; 123(4):1011-24. PubMed ID: 14751292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPA receptor positive allosteric modulators: a patent review.
    Pirotte B; Francotte P; Goffin E; de Tullio P
    Expert Opin Ther Pat; 2013 May; 23(5):615-28. PubMed ID: 23405869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In search of novel AMPA potentiators.
    Francotte P; de Tullio P; Fraikin P; Counerotte S; Goffin E; Pirotte B
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):239-46. PubMed ID: 18221205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.
    Black MD
    Psychopharmacology (Berl); 2005 Apr; 179(1):154-63. PubMed ID: 15672275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators.
    Pirotte B; Francotte P; Goffin E; Fraikin P; Danober L; Lesur B; Botez I; Caignard DH; Lestage P; de Tullio P
    Curr Med Chem; 2010; 17(30):3575-82. PubMed ID: 20738245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptors as drug targets in neurological disease--advantages, caveats, and future outlook.
    Chang PK; Verbich D; McKinney RA
    Eur J Neurosci; 2012 Jun; 35(12):1908-16. PubMed ID: 22708602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders.
    Marenco S; Weinberger DR
    CNS Drugs; 2006; 20(3):173-85. PubMed ID: 16529524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
    Raevskiĭ KS; Eremin KO
    Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors.
    Siuda ER; Quirk JC; Nisenbaum ES
    Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.